This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:
Less than 5% of patients with dystonia—a debilitating neurological movement disorder—undergo deep brain stimulation (DBS) treatment, even though it is one of the few interventions that directly target the abnormal brain processes underlying the condition. The surgical treatment is highly underutilized, likely due to its invasiveness and the lack of objective markers of who may benefit. Even among those who undergo surgery, outcomes vary widely, depending on patient characteristics and external influences.
Currently, no neural biomarkers exist that help clinicians predict whether a patient with dystonia will benefit from DBS. Therefore, Mass General Brigham researchers set out to develop an automated platform that could objectively predict DBS treatment response by identifying relevant patterns in a patient's brain MRI.
The research, "DystoniaDBSNet as a novel deep learning biomarker of predictive deep brain stimulation outcome in dystonia," is published in npj Digital Medicine. Kristina Simonyan, M.D., Ph.D., DrMed, of Mass Eye and Ear and the Mass General Brigham Neuroscience Institute, is the senior author.
The team developed DystoniaDBSNet, a deep learning algorithm that analyzes patients' preoperative MRIs to identify brain patterns associated with treatment response and predicts their likelihood of benefiting from DBS. Importantly, it makes this prediction before surgery, when it can help inform candidate selection and treatment planning.
The algorithm was trained, independently tested and externally validated in an international cohort from leading DBS centers.
Source link







